Micro Emerging Active

PFE TALZENNA Fase 3 Hasil

New narrative with limited coverage — still forming.

Skor
0,3
Kecepatan
▲ 0,0
Artikel
2
Sumber
1

Sentiment Timeline

Event Timeline

Mar 28, 2026
Guggenheim Sees Favorable Risk-Reward for Pfizer (PFE) Ahead of Phase 3 Data Bullish
Mar 27, 2026
Pfizer Inc. (PFE) Announces Positive Topline Results From Phase 3 TALAPRO-3 Study … Neutral

Lini Waktu

Pertama TerlihatMar 27, 2026
Terakhir DiperbaruiMar 27, 2026